Mortality | HRa (95% CI) | Purulent | HRb (95% CI) | Non-Purulent | HRb (95% CI) |
|---|
SSTVI Mortality | 0.76 (0.72–0.80) | OP | 0.96 (0.95–0.97) | OP | 0.88 (0.87–0.88) |
|  |  | ED | 0.99 (0.98–1.01) | ED | 0.98 (0.97–0.99) |
|  |  | IP | 0.99 (0.97–1.01) | IP | 0.99 (0.98–1.00) |
|  |  | IPC | 1.00 (0.98–1.02) | IPC | 1.00 (0.98–1.01) |
|  |  | PDD | 1.00 (0.96–1.05) | PDD | 0.99 (0.96–1.02) |
- CI confidence interval, ED emergency department; HR = hazard ratio; IP = inpatient; IPC = inpatient complications; NSP = needle and syringe programs; OP = outpatient; PDD = patient-directed discharge; SSTVI = skin, soft tissue, and vascular infections
- aFor SSTVI mortality, we conducted a competing risk analysis using the Fine-Gray model to derive the hazard ratio
- bFor health service use, we conducted a recurrent event analysis using the marginal mean model to derive the hazard ratio
- Note: The results in this table were compiled using data from the © Government of Québec (Research file publication date: 2009–2019; Data use approval date: 20 September 2021)
